# Robot-Assisted Hematoma Evacuation With Intrahematoma Tenecteplase for Post-Reperfusion PH2 Hemorrhagic Transformation

> **NCT07641998** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Hemorrhagic Transformation Stroke

## Interventions

- **DRUG:** Robot-assisted stereotactic hematoma aspiration plus intrahematoma tenecteplase

## Key facts

- **NCT ID:** NCT07641998
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-10
- **Primary completion:** 2026-12-10
- **Final completion:** 2026-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641998, "Robot-Assisted Hematoma Evacuation With Intrahematoma Tenecteplase for Post-Reperfusion PH2 Hemorrhagic Transformation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*